Salvia officinalis-based green-mediated vanadium nanoparticles:
Describing a modern chemotherapeutic drug for the treatment of
colorectal carcinoma
Abstract
In this study, vanadium nanoparticles were green synthesized using the
aqueous extract of Salvia officinalis. Different techniques such as
FE-SEM, XRD, FT-IR, and EDS analysis were used to characterize
VNPs@Salvia officinalis. A 25.6 nm was obtained for the crystal size of
the vanadium nanoparticles using XRD analysis. The FE-SEM images show a
spherical morphology for VNPs@Salvia officinalis with the range size of
11.28 to 40.74 for the synthetic nanoparticles. In the antioxidant test,
the IC50 of VNPs@Salvia officinalis and BHT against DPPH free radicals
were 300 and 265 µg/mL, respectively. For anticancer activity evaluation
the treated cells with VNPs@Salvia officinalis were assessed by MTT
assay for 48h about the cytotoxicity and anti-colorectal cancer
properties on normal (HUVEC) and colorectal cancer cell lines i.e.,
Caco-2, COLO 320, DLD-1, HCT-15, HCT-116, and HT-29. The IC50 of
VNPs@Salvia officinalis were 213, 210, 297, 204, 160, and 125 µg/mL
against Caco-2, COLO 320, DLD-1, HCT-15, HCT-116, and HT-29 cell
lines, respectively. The viability of malignant colorectal cell lines
reduced dose-dependently in the presence of VNPs@Salvia officinalis. It
appears that the anti-colorectal cancer effect of VNPs@Salvia
officinalis is due to their antioxidant effects.